Monday 29th April 2013 |
Text too small? |
Former Prime Minister Jenny Shipley has disclosed her role at the failed Mainzeal Group to China Construction Bank, the world's second-biggest lender by market value, where she is a director.
The Chinese lender said Shipley had notified it that she had served as chairman and independent director of the group which was put in receivership on Feb. 6 and liquidation on Feb. 28.
"Based on information available to Dame Jenny Shipley the total amount involved in the liquidation of Mainzeal has not been finalised as at the date of this announcement, but likely to be $70 million or above," China Construction said in a statement to the Hong Kong stock exchange. As Mainzeal is still being liquidated she is "not in a position to indicate the possible outcome of liquidation proceedings."
Shipley was appointed chairman and director of Mainzeal Property and Construction on April 1, 2004, and resigned on Dec. 31 last year, the same day she was appointed chair and director of Mainzeal Group, before she resigned from that related entity on Feb. 5
Shipley will stand down as a director of China Construction at its annual shareholders' meeting as one of three independent non-executive directors who are retiring by rotation from the board, the newzealandinc.com website reported on April 17. Her place would be taken by former Treasury secretary Murray Horn.
Shipley was grilled about her suitability as chair for state-owned electricity company Genesis Energy when she appeared before the commerce select committee in early March and would not answer calls from Labour's Clayton Cosgrove for assurances there was nothing relating to her Mainzeal role which could damage Genesis's reputation.
BusinessDesk.co.nz
No comments yet
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report